NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The project stands to breathe new life into a large suburban property that has been underutilized since Trinity closed in-person undergraduate programs there in 2023.Read More